Skip to main content

View full-text article in PMC

. 2021 Aug 20;8(10):ofab436. doi: 10.1093/ofid/ofab436

Table 2.

CMV Serostatus

	HD Patients			Non-HD Patients
CMV Serostatus^b	Liver (n = 31)	Heart (n = 4)	Lung (n = 2)	Liver (n = 80)	Heart (n = 17)	Lung (n = 11)	Heart/Liver (n = 3)	P value^a
Donor +/Recipient –	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	.61
Donor +/Recipient +	22 (71.0)	4 (100)	2 (100)	60 (75.0)	5 (29.4)	7 (63.6)	2 (66.7)
Donor –/Recipient +	6 (19.3)	0 (0.0)	0 (0.0)	13 (16.3)	7 (41.2)	1 (9.1)	1 (33.3)
Donor –/Recipient –	3 (9.7)	0 (0.0)	0 (0.0)	7 (8.8)	5 (29.4)	3 (27.3)	0 (0.0)

^aOverall P value comparing HD vs. non-HD patients.

^bAll data expressed as n (%).

Abbreviations: CMV, cytomegalovirus; HD, hemodialysis.